Literature DB >> 21412717

Genetics of familial Amyotrophic lateral sclerosis.

Nicola Ticozzi1, Cinzia Tiloca, Claudia Morelli, Claudia Colombrita, Barbara Poletti, Alberto Doretti, Luca Maderna, Stefano Messina, Antonia Ratti, Vincenzo Silani.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a late onset, rapidly progressive and ultimately fatal neurodegenerative disease, caused by the loss of motor neurons in the brain and spinal cord. About 10% of all ALS cases are familial (FALS), and constitute a clinically and genetically heterogeneous entity. To date, FALS has been linked to mutations in 10 different genes and to four additional chromosomal loci. Research on FALS genetics, and in particular the discoveries of mutations in the SOD1, TARDBP, and FUS genes, has provided essential information toward the understanding of the pathogenesis of ALS in general. This review presents a tentative classification of all FALS-associated genes identified so far.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412717     DOI: 10.4449/aib.v149i1.1262

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  31 in total

1.  Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.

Authors:  Romel Somwar; Hediye Erdjument-Bromage; Erik Larsson; David Shum; William W Lockwood; Guangli Yang; Chris Sander; Ouathek Ouerfelli; Paul J Tempst; Hakim Djaballah; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

3.  Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS).

Authors:  Zi Chao Zhang; Yuh Min Chook
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 4.  Amyotrophic lateral sclerosis and skeletal muscle: an update.

Authors:  O Pansarasa; D Rossi; A Berardinelli; C Cereda
Journal:  Mol Neurobiol       Date:  2013-11-08       Impact factor: 5.590

5.  C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository.

Authors:  Nicola J Rutherford; Mariely DeJesus-Hernandez; Matt C Baker; Thomas B Kryston; Patricia E Brown; Catherine Lomen-Hoerth; Kevin Boylan; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

6.  The distinct genetic pattern of ALS in Turkey and novel mutations.

Authors:  Aslıhan Özoğuz; Özgün Uyan; Güneş Birdal; Ceren Iskender; Ece Kartal; Suna Lahut; Özgür Ömür; Zeynep Sena Agim; Aslı Gündoğdu Eken; Nesli Ece Sen; Pınar Kavak; Ceren Saygı; Peter C Sapp; Pamela Keagle; Yeşim Parman; Ersin Tan; Filiz Koç; Feza Deymeer; Piraye Oflazer; Haşmet Hanağası; Hakan Gürvit; Başar Bilgiç; Hacer Durmuş; Mustafa Ertaş; Dilcan Kotan; Mehmet Ali Akalın; Halil Güllüoğlu; Mehmet Zarifoğlu; Fikret Aysal; Nilgün Döşoğlu; Kaya Bilguvar; Murat Günel; Özlem Keskin; Tahsin Akgün; Hilmi Özçelik; John E Landers; Robert H Brown; A Nazlı Başak
Journal:  Neurobiol Aging       Date:  2015-01-10       Impact factor: 4.673

Review 7.  Regulation of CuZnSOD and its redox signaling potential: implications for amyotrophic lateral sclerosis.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2013-08-01       Impact factor: 8.401

8.  Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.

Authors:  Dan Krakora; Patrick Mulcrone; Michael Meyer; Christina Lewis; Ksenija Bernau; Genevieve Gowing; Chad Zimprich; Patrick Aebischer; Clive N Svendsen; Masatoshi Suzuki
Journal:  Mol Ther       Date:  2013-05-28       Impact factor: 11.454

9.  Regulation of FMO and PON detoxication systems in ALS human tissues.

Authors:  Stella Gagliardi; Kenneth Abel; Marika Bianchi; Pamela Milani; Stefano Bernuzzi; Manuel Corato; Mauro Ceroni; John R Cashman; Cristina Cereda
Journal:  Neurotox Res       Date:  2012-10-17       Impact factor: 3.911

10.  Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Andrea Fuchs; Sylvie Kutterer; Tobias Mühling; Johanna Duda; Burkhard Schütz; Birgit Liss; Bernhard U Keller; Jochen Roeper
Journal:  J Physiol       Date:  2013-02-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.